Kaiser J Phillip, Guo Luping, Beier Juliane I, Zhang Jun, Bhatnagar Aruni, Arteel Gavin E
Department of Pharmacology and Toxicology , University of Louisville Health Sciences Center, Louisville, Kentucky; University of Louisville Alcohol Research Center , Louisville, Kentucky.
Alcohol Clin Exp Res. 2014 Mar;38(3):801-9. doi: 10.1111/acer.12324. Epub 2014 Jan 31.
Protein kinase C epsilon (PKCε) has been shown to play a role in experimental steatosis by acute alcohol. The "two-hit" hypothesis implies that preventing steatosis should blunt more advanced liver damage (e.g., inflammation and necrosis). However, the role of PKCε in these pathologies is not yet known. The goal of this current work was to address this question in a model of chronic alcohol exposure using antisense oligonucleotides (ASO) against PKCε.
Accordingly, PKCε ASO- and saline-treated mice were fed high-fat control or ethanol (EtOH)-containing enteral diets for 4 weeks.
Chronic EtOH exposure significantly elevated hepatic lipid pools as well as activated PKCε. The PKCε ASO partially blunted the increases in hepatic lipids caused by EtOH. Administration of PKCε ASO also completely prevented the increase in the expression of fatty acid synthase, and tumor necrosis factor α caused by EtOH. Despite these protective effects, the PKCε ASO was unable to prevent the increases in inflammation and necrosis caused by chronic EtOH. These latter results correlated with an inability of the PKCε ASO to blunt the up-regulation of plasminogen activator inhibitor-1 (PAI-1) and the accumulation of fibrin. Importantly, PAI-1 has been previously shown to more robustly mediate inflammation and necrosis (vs. steatosis) after chronic EtOH exposure.
This study identifies a novel potential mechanism where EtOH, independent of steatosis, can contribute to liver damage. These results also suggest that PAI-1 and fibrin accumulation may be at the center of this PKCε-independent pathway.
蛋白激酶Cε(PKCε)已被证明在急性酒精所致的实验性脂肪变性中发挥作用。“二次打击”假说表明,预防脂肪变性应能减轻更严重的肝损伤(如炎症和坏死)。然而,PKCε在这些病理过程中的作用尚不清楚。本研究的目的是在慢性酒精暴露模型中,使用针对PKCε的反义寡核苷酸(ASO)来解决这个问题。
相应地,给经PKCε ASO和生理盐水处理的小鼠喂食高脂对照或含乙醇(EtOH)的肠内饮食4周。
慢性EtOH暴露显著升高了肝脏脂质池并激活了PKCε。PKCε ASO部分减弱了EtOH所致的肝脏脂质增加。给予PKCε ASO还完全阻止了EtOH所致的脂肪酸合酶和肿瘤坏死因子α表达的增加。尽管有这些保护作用,PKCε ASO仍无法阻止慢性EtOH所致的炎症和坏死增加。后一组结果与PKCε ASO无法减弱纤溶酶原激活物抑制剂-1(PAI-1)的上调和纤维蛋白的积累有关。重要的是,先前已表明PAI-1在慢性EtOH暴露后更有力地介导炎症和坏死(相对于脂肪变性)。
本研究确定了一种新的潜在机制,即EtOH可独立于脂肪变性而导致肝损伤。这些结果还表明,PAI-1和纤维蛋白积累可能是这条不依赖PKCε的途径的核心。